MedPath

A multi-centre randomised controlled trial of a pelvic floor muscle training intervention for women with pelvic organ prolapse

Completed
Conditions
Urological and Genital Diseases
Pelvic organ prolapse
Noninflammatory disorders of female genital tract
Registration Number
ISRCTN35911035
Lead Sponsor
Glasgow Caledonian University (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
556
Inclusion Criteria

Potential participants will be new attendees at outpatient gynaecology clinics presenting with symptoms of prolapse. At their clinic appointment, type and stage of prolapse will be confirmed by their gynaecologist using the Pevic Organ Prolapse Quantification (POP-Q) grading system. Women with any type of prolapse will be included:
1. Anterior vaginal wall prolapse (urethrocele, cystocele, paravaginal defect)
2. Uterine/cervical prolapse
3. Vaginal vault (after hysterectomy) prolapse
4. Posterior vaginal wall prolapse (enterocele, rectocele, perineal deficiency)

Exclusion Criteria

1. Stage four prolapse
2. Previous treatment for prolapse (surgery or formal instruction in pelvic floor muscle training [PFMT])
3. Unable to comply with PFMT treatment
4. Local atrophy
5. Pregnant
6. Unable to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Prolapse symptom score (questions developed in feasibility study and undergoing validation)<br>2. The primary economic outcome measures of cost effectiveness are:<br>2.1. Use of health services,<br>2.2. Average number of days of prolapse symptoms, and<br>2.3. Further prolapse treatment needed/received
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include:<br>1. Prolapse-related quality of life (single item scored zero to ten)<br>2. Prolapse severity (POP-Q)<br>3. Need for further prolapse treatment including a pessary or surgery<br><br>Other outcomes include:<br>1. Lifestyle changes<br>2. Urinary symptoms (International Consultation on Incontinence Questionnaire [ICIQ] short-form)<br>3. Bowel symptoms (ICIQ bowel symptoms module)<br>4. Sexual symptoms (Prolapse Incontinence Sexual Questionnaire [PISQ])<br>5. General health status (Short Form health survey [SF-12])
© Copyright 2025. All Rights Reserved by MedPath